Summary

The Mental Health Screening market is projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% during the forecast period. The rising awareness of mental health issues
due to the growing geriatric population and subsequent increase in prevalence of mental disorders, and increasing focus on remote monitoring are the factors that will drive the growth of this market. On the other hand, stigma and limited awareness, and data privacy concerns may impede the adoption of mental health screening solutions to a certain extent over the forecast period.

“AI-based Screening Tools is expected to register highest growth in the forecast period, by technology segment.”
Based on technology, the Mental Health Screening market is segmented into self-screening mHealth apps, telehealth & virtual care solutions, continuous monitoring wearable devices, AI-based screening tools, and remote mental health platforms. The AI-based screening tools segment is projected to witness the highest growth rate during the forecast period. Growth in this market can be attributed to the increasing demand for scalable and accurate solutions in mental health screening, coupled with advancements in AI technology.

“Clinical settings segment is estimated to hold the largest share of Mental Health Screening market, by setting.”
Based on setting, the global mental health screening market is segmented into clinical settings, educational institutions, workplace/corporate programs, online platforms, and other settings. The clinical settings segment accounted for the largest share of the mental health screening market in 2022. This segment is expected to witness significant growth due to increased awareness, the rising prevalence of mental health disorders, technological advancements, policy support, and a shift towards preventive and patient-centered care.

“The Seniors (age 65 and above) segment is expected to register highest growth in the forecast period, by age-group.”
Based on age group, the mental health screening market is segmented into children & adolescents (age 0–18 years), adults (age 19–64 years), and seniors (age 65 and above). The seniors segment is projected to witness the highest growth rate during the forecast period. The growth of mental health screening solutions adoption among seniors is driven by the rising geriatric population and the subsequent increase in age-related conditions like dementia, Alzheimer’s disease, and late-life depression.


“Asia Pacific to register the highest growth in the Mental Health Screening market in the forecast period.”
The global Mental Health Screening market is segmented into four major regions, namely, North America, Europe, APAC, and the Rest of the World. In 2022, Asia Pacific was expected to register the highest growth for Mental Health Screening solutions in the forecast period. Factors such as increasing patient burden, improved accessibility of mental health services due to the growing incidence of mental disorders, and rising government initiatives for increasing awareness about mental disorders are expected to drive the growth of the Mental Health Screening market in the Asia Pacific.

Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:
• By Supply Side: Tier 1 (25%), Tier 2 (5%), and Tier 3 (70%)
• By Designation: C-level Executives (27%), Director-level (18%), and Managers (55%)
• By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and Middle East and Africa (2%)

The prominent players in mental health screening market are Adaptive Testing Technologies (US), Proem Behavioral Health (US), Aiberry (US), SonderMind Inc. (US), Clarigent Health (US), Riverside Community Care (US), Kintsugi Mindful Wellness, Inc. (US), Thymia Limited (UK), Ellipsis Health Inc. (US), Canary Speech, Inc. (US), Headspace Health (US), Quartet Health, Inc. (US), Modern Life, Inc. (US), Sonde Health, Inc. (US), FuturesTHRIVE (US), Koninklijke Philips N.V. (Netherlands), Alphabet Inc. (Fitbit) (US), ResMed (US), Apple Inc. (US), MoodFit (US), Wellin5 USA Inc. (Canada), MoodTools (US), Cognitive Health Solutions LLC (US), Woebot Labs Inc. (US), and CogniABle (India). Players adopted organic as well as inorganic growth strategies such as partnerships, acquisitions, and product launches to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage
• The report studies the Mental Health Screening market based on application, screening method, technology, age group, setting, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Mental Health Screening market.
• The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:
 Analysis of key drivers (growing geriatric population and subsequent increase in prevalence of mental disorders, rising awareness of mental health issues, technological advancements, increasing focus on remote monitoring), restraints (stigma and limited awareness, and Data privacy concerns), opportunities (integration with wearable technologies, and rise of social media and its impact on adoption of mental health screening tools) and challenge (Integration with wearable technologies).
 Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the Mental Health Screening market.
 Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of Mental Health Screening solutions across regions.
 Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the Mental Health Screening market.
 Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the Mental Health Screening market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 71
1.1 STUDY OBJECTIVES 71
1.2 MARKET DEFINITION 71
1.2.1 INCLUSIONS & EXCLUSIONS 72
1.3 MARKET SCOPE 73
1.3.1 MARKET SEGMENTATION 73
FIGURE 1 MENTAL HEALTH SCREENING MARKET SEGMENTATION 73
1.3.2 REGIONAL SEGMENTATION 74
FIGURE 2 MENTAL HEALTH SCREENING MARKET: REGIONAL SEGMENTATION 74
1.3.3 YEARS CONSIDERED 74
1.4 STAKEHOLDERS 75
1.5 CURRENCY CONSIDERED 75
2 RESEARCH METHODOLOGY 76
2.1 RESEARCH DATA 76
2.2 RESEARCH APPROACH 76
FIGURE 3 RESEARCH APPROACH 76
2.2.1 SECONDARY DATA 77
2.2.1.1 Key data from secondary sources 77
2.2.2 PRIMARY DATA 78
FIGURE 4 PRIMARY SOURCES 78
2.2.2.1 Key data from primary sources 79
2.2.2.2 Key industry insights 80
2.2.2.3 Breakdown of primaries 80
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 80
2.3 MARKET SIZE ESTIMATION 81
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 81
FIGURE 7 MENTAL HEALTH SCREENING MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR KONINKLIJKE PHILIPS 82
FIGURE 8 CAGR PROJECTIONS 84
FIGURE 9 IMPACT ON MARKET GROWTH AND CAGR: ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029) 85
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 86
FIGURE 10 DATA TRIANGULATION METHODOLOGY 86
2.5 MARKET SHARE ESTIMATION 87
2.6 STUDY ASSUMPTIONS 87
2.7 LIMITATIONS 87
2.7.1 METHODOLOGY-RELATED LIMITATIONS 87
2.7.2 SCOPE-RELATED LIMITATIONS 88
2.8 RISK ASSESSMENT 88
TABLE 1 RISK ASSESSMENT: MENTAL HEALTH SCREENING MARKET 88
2.9 IMPACT OF RECESSION ON MENTAL HEALTH SCREENING MARKET 88
3 EXECUTIVE SUMMARY 89
FIGURE 11 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION) 89
FIGURE 12 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2023 VS. 2029 (USD MILLION) 90
FIGURE 13 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 90
FIGURE 14 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2023 VS. 2029 (USD MILLION) 91
FIGURE 15 MENTAL HEALTH SCREENING MARKET, BY SETTING, 2023 VS. 2029 (USD MILLION) 92
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MENTAL HEALTH SCREENING MARKET 93
4 PREMIUM INSIGHTS 94
4.1 MENTAL HEALTH SCREENING MARKET OVERVIEW 94
FIGURE 17 GROWING INCIDENCE OF MENTAL HEALTH DISORDERS TO DRIVE MARKET 94
4.2 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION AND COUNTRY (2022) 95
FIGURE 18 PHYSIOLOGICAL DISORDERS ACCOUNTED FOR LARGEST SHARE OF MENTAL HEALTH SCREENING MARKET IN 2022 95
4.3 MENTAL HEALTH SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 96
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 96
4.4 MENTAL HEALTH SCREENING MARKET, BY REGION (2020−2027) 97
FIGURE 20 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD 97
4.5 MENTAL HEALTH SCREENING MARKET: DEVELOPED VS. EMERGING ECONOMIES 97
FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 97
5 MARKET OVERVIEW 98
5.1 INTRODUCTION 98
5.2 MARKET DYNAMICS 98
FIGURE 22 MENTAL HEALTH SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 98
5.2.1 DRIVERS 99
5.2.1.1 Growing geriatric population and subsequent increase in prevalence of mental disorders 99
5.2.1.2 Rising awareness of mental health issues 99
5.2.1.3 Technological advancements 100
5.2.1.4 Increasing focus on remote monitoring 101
5.2.2 RESTRAINTS 101
5.2.2.1 Stigma and limited awareness 101
5.2.2.2 Data privacy concerns 102
5.2.3 OPPORTUNITIES 103
5.2.3.1 Integration with wearable technologies 103
5.2.3.2 Rise of social media and its impact on adoption of mental health screening tools 103
5.2.4 CHALLENGES 104
5.2.4.1 Concerns regarding accuracy and validity 104
5.3 KEY INDUSTRY TRENDS 104
5.3.1 INTEGRATION WITH PRIMARY CARE SETTINGS 104
5.3.2 DIGITAL AND REMOTE SOLUTIONS 105
5.4 PRICING ANALYSIS 106
TABLE 2 AVERAGE SELLING PRICE TREND, BY REGION 106
TABLE 3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY 106
5.5 VALUE/SUPPLY CHAIN ANALYSIS 107
5.5.1 RESEARCH & DEVELOPMENT 107
5.5.2 MANUFACTURING & PRODUCTION 107
5.5.3 DISTRIBUTION 107
5.5.4 MARKETING & SALES 107
5.5.5 POST-SALES SERVICES 107
FIGURE 23 MENTAL HEALTH SCREENING MARKET: VALUE CHAIN ANALYSIS 108
5.6 ECOSYSTEM ANALYSIS 108
5.7 PORTER’S FIVE FORCES ANALYSIS 109
TABLE 4 PORTER’S FIVE FORCES ANALYSIS: MENTAL HEALTH SCREENING MARKET 109
5.7.1 INTENSITY OF COMPETITIVE RIVALRY 110
5.7.2 BARGAINING POWER OF SUPPLIERS 110
5.7.3 BARGAINING POWER OF BUYERS 110
5.7.4 THREAT OF NEW ENTRANTS 110
5.7.5 THREAT OF SUBSTITUTES 110
5.8 REGULATORY LANDSCAPE 111
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
5.8.2 REGULATORY ANALYSIS 112
5.8.2.1 North America 112
5.8.2.2 Europe 112
5.8.2.3 Asia Pacific 113
5.8.2.4 Latin America 113
5.8.2.5 Middle East & Africa 113
5.9 TECHNOLOGY ANALYSIS 114
5.9.1 KEY TECHNOLOGIES 114
5.9.1.1 Artificial Intelligence (AI) & Machine Learning (ML) 114
5.9.1.2 Telehealth platforms 114
5.9.1.3 Mobile apps and platforms 114
5.9.2 COMPLEMENTARY TECHNOLOGIES 114
5.9.2.1 Electronic Health Records (EHRs) 114
5.9.2.2 Chatbots and virtual assistants 114
5.9.3 ADJACENT TECHNOLOGIES 115
5.9.3.1 Genetic and biological markers 115
5.10 PATENT ANALYSIS 115
5.10.1 PATENT PUBLICATION TRENDS FOR MENTAL HEALTH SCREENING 115
5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES 115
FIGURE 24 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MENTAL HEALTH SCREENING PATENTS, 2012–2023 115
5.10.3 MAJOR PATENTS IN MENTAL HEALTH SCREENING MARKET 116
FIGURE 25 MAJOR PATENTS FOR MENTAL HEALTH SCREENING SOLUTIONS (2012–2023) 116
5.10.4 PATENTS FILED 117
5.11 TRADE ANALYSIS 119
FIGURE 26 PRODUCT EXPORTS UNDER HSN CODE: 9113, BY COUNTRY, 2022 (USD THOUSAND) 120
FIGURE 27 PRODUCT IMPORTS UNDER HSN CODE 9113, BY COUNTRY, 2022 (USD THOUSAND) 120
5.12 CASE STUDY ANALYSIS 121
TABLE 6 CASE STUDY 1: AIBERRY'S COLLABORATIVE CLINICAL STUDY WITH UNIVERSITY OF ARIZONA FOR AI-POWERED MENTAL HEALTH SCREENING PLATFORM 121
TABLE 7 CASE STUDY 2: IMPACT OF MINDWISE SCREENING PROGRAM AT HARVARD UNIVERSITY 121
5.13 KEY CONFERENCES & EVENTS, 2024–2025 122
5.13.1 LIST OF KEY CONFERENCES & EVENTS IN MENTAL HEALTH SCREENING MARKET, 2024–2025 122
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 124
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 124
TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MENTAL HEALTH SCREENING SOLUTIONS 124
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY 125
5.14.2 BUYING CRITERIA 125
FIGURE 28 KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY 125
TABLE 10 KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY 125
5.15 UNMET NEEDS 126
TABLE 11 UNMET NEEDS IN MENTAL HEALTH SCREENING MARKET 126
5.15.1 END-USER EXPECTATIONS 127
TABLE 12 END-USER EXPECTATIONS IN MENTAL HEALTH SCREENING MARKET 127
 
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 128
FIGURE 29 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR MENTAL HEALTH SCREENING MARKET 128
5.17 REIMBURSEMENT SCENARIO ANALYSIS 128
TABLE 13 CPT CODES AND REIMBURSEMENT ANALYSIS IN MENTAL HEALTH SCREENING MARKET IN US 129
5.18 BUSINESS MODEL ANALYSIS 129
5.19 INVESTMENT & FUNDING SCENARIO 130
FIGURE 30 INVESTOR DEALS AND VC FUNDING OF US-BASED MENTAL HEALTH STARTUPS INCREASED IN 2020 130
6 MENTAL HEALTH SCREENING MARKET, BY APPLICATION 131
6.1 INTRODUCTION 132
TABLE 14 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 132
TABLE 15 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 133
6.2 PHYSIOLOGICAL DISORDERS 133
TABLE 16 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 133
TABLE 17 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 134
TABLE 18 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 134
TABLE 19 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 135
6.2.1 DEPRESSION 135
6.2.1.1 Increased adoption of depression screening to drive market 135
TABLE 20 MENTAL HEALTH SCREENING MARKET FOR DEPRESSION, BY COUNTRY, 2018–2021 (USD MILLION) 137
TABLE 21 MENTAL HEALTH SCREENING MARKET FOR DEPRESSION, BY COUNTRY, 2022–2029 (USD MILLION) 138
6.2.2 ANXIETY 138
6.2.2.1 Increasing burden of anxiety disorders & rising awareness to fuel market growth 138
TABLE 22 MENTAL HEALTH SCREENING MARKET FOR ANXIETY, BY COUNTRY, 2018–2021 (USD MILLION) 140
TABLE 23 MENTAL HEALTH SCREENING MARKET FOR ANXIETY, BY COUNTRY, 2022–2029 (USD MILLION) 141
6.2.3 POST-TRAUMATIC STRESS DISORDER (PTSD) 141
6.2.3.1 Rising number of initiatives for PTSD to propel market 141
TABLE 24 MENTAL HEALTH SCREENING MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2018–2021 (USD MILLION) 142
TABLE 25 MENTAL HEALTH SCREENING MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2022–2029 (USD MILLION) 143
6.2.4 BIPOLAR DISORDER 143
6.2.4.1 Growing public awareness to drive bipolar disorder screening uptake 143
TABLE 26 MENTAL HEALTH SCREENING MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2018–2021 (USD MILLION) 144
TABLE 27 MENTAL HEALTH SCREENING MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2022–2029 (USD MILLION) 145
6.2.5 EATING DISORDER 145
6.2.5.1 Increasing incidence and hospital visits to drive adoption of eating disorder screening 145
FIGURE 31 GLOBAL EATING DISORDER PREVALENCE, BY AGE, 2015–2019 146
TABLE 28 MENTAL HEALTH SCREENING MARKET FOR EATING DISORDER, BY COUNTRY, 2018–2021 (USD MILLION) 147
TABLE 29 MENTAL HEALTH SCREENING MARKET FOR EATING DISORDER, BY COUNTRY, 2022–2029 (USD MILLION) 147
6.2.6 SUBSTANCE USE 148
6.2.6.1 Increasing cases of substance use to drive market 148
TABLE 30 MENTAL HEALTH SCREENING MARKET FOR SUBSTANCE USE, BY COUNTRY, 2018–2021 (USD MILLION) 149
TABLE 31 MENTAL HEALTH SCREENING MARKET FOR SUBSTANCE USE, BY COUNTRY, 2022–2029 (USD MILLION) 150
6.2.7 OTHER PHYSIOLOGICAL DISORDERS 150
TABLE 32 MENTAL HEALTH SCREENING MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 151
TABLE 33 MENTAL HEALTH SCREENING MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 151
6.3 PSYCHIATRIC DISORDERS 152
TABLE 34 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 152
TABLE 35 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 152
TABLE 36 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 153
TABLE 37 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 153
6.3.1 SCHIZOPHRENIA 154
6.3.1.1 Advancements in screening tools for schizophrenia to support growth 154
TABLE 38 MENTAL HEALTH SCREENING MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2018–2021 (USD MILLION) 155
TABLE 39 MENTAL HEALTH SCREENING MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2022–2029 (USD MILLION) 155
6.3.2 PSYCHOTIC DISORDER 156
6.3.2.1 Increasing need for screening tools for early detection to drive market growth 156
TABLE 40 MENTAL HEALTH SCREENING MARKET FOR PSYCHOTIC DISORDER, BY COUNTRY, 2018–2021 (USD MILLION) 156
TABLE 41 MENTAL HEALTH SCREENING MARKET FOR PSYCHOTIC DISORDER,
BY COUNTRY, 2022–2029 (USD MILLION) 157
6.3.3 DISSOCIATIVE DISORDER 157
6.3.3.1 Growing awareness and education through screening and content creation to favor market growth 157
TABLE 42 MENTAL HEALTH SCREENING MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2018–2021 (USD MILLION) 158
TABLE 43 MENTAL HEALTH SCREENING MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2022–2029 (USD MILLION) 159
6.3.4 OBSESSIVE COMPULSIVE DISORDER (OCD) 159
6.3.4.1 Advancements in assessment tools to support market growth 159
TABLE 44 MENTAL HEALTH SCREENING MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2018–2021 (USD MILLION) 160
TABLE 45 MENTAL HEALTH SCREENING MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2022–2029 (USD MILLION) 160
6.3.5 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) 161
6.3.5.1 Increasing cases & diagnosis to contribute to increased demand for ADHD screening 161
TABLE 46 MENTAL HEALTH SCREENING MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2018–2021 (USD MILLION) 161
TABLE 47 MENTAL HEALTH SCREENING MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2022–2029 (USD MILLION) 162
6.3.6 OTHER PSYCHIATRIC DISORDERS 162
TABLE 48 MENTAL HEALTH SCREENING MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 163
TABLE 49 MENTAL HEALTH SCREENING MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 163
6.4 BEHAVIORAL DISORDERS 164
TABLE 50 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,
BY TYPE, 2018–2021 (USD MILLION) 164
TABLE 51 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,
BY TYPE, 2022–2029 (USD MILLION) 164
TABLE 52 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,
BY COUNTRY, 2018–2021 (USD MILLION) 165
TABLE 53 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,
BY COUNTRY, 2022–2029 (USD MILLION) 165
6.4.1 SELF-HARM 166
6.4.1.1 Advancements in screening technologies to drive awareness and growth in self-harm screening market 166
TABLE 54 MENTAL HEALTH SCREENING MARKET FOR SELF-HARM DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 166
TABLE 55 MENTAL HEALTH SCREENING MARKET FOR SELF-HARM DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 167
6.4.2 AGGRESSION 167
6.4.2.1 Rising cases of workplace aggression to propel demand for aggression screening 167
TABLE 56 MENTAL HEALTH SCREENING MARKET FOR AGGRESSION DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 168
TABLE 57 MENTAL HEALTH SCREENING MARKET FOR AGGRESSION DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 168
6.4.3 SLEEP DISORDERS 169
6.4.3.1 Increased stress and unhealthy lifestyles among adults to drive market 169
TABLE 58 MENTAL HEALTH SCREENING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 170
TABLE 59 MENTAL HEALTH SCREENING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 170
6.4.4 SOCIAL WITHDRAWAL 171
6.4.4.1 Increasing adolescent loneliness to drive demand for social withdrawal screening 171
TABLE 60 MENTAL HEALTH SCREENING MARKET FOR SOCIAL WITHDRAWAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 172
TABLE 61 MENTAL HEALTH SCREENING MARKET FOR SOCIAL WITHDRAWAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 172
6.4.5 HYPERACTIVITY 173
6.4.5.1 Increased awareness and recognition to drive growth 173
TABLE 62 MENTAL HEALTH SCREENING MARKET FOR HYPERACTIVITY DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 173
TABLE 63 MENTAL HEALTH SCREENING MARKET FOR HYPERACTIVITY DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 174
6.4.6 OTHER BEHAVIORAL DISORDERS 174
TABLE 64 MENTAL HEALTH SCREENING MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 175
TABLE 65 MENTAL HEALTH SCREENING MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 175
6.5 COGNITIVE DISORDERS 176
TABLE 66 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 176
TABLE 67 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 68 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 177
TABLE 69 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 178
6.5.1 COGNITIVE IMPAIRMENT 178
6.5.1.1 Growing geriatric population and rising incidence of neurodegenerative disorders to support market growth 178
TABLE 70 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2018–2021 (USD MILLION) 179
TABLE 71 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2022–2029 (USD MILLION) 180
6.5.2 DEMENTIA 180
6.5.2.1 Rising initiatives to promote dementia screening awareness to fuel market 180
TABLE 72 MENTAL HEALTH SCREENING MARKET FOR DEMENTIA, BY COUNTRY, 2018–2021 (USD MILLION) 181
TABLE 73 MENTAL HEALTH SCREENING MARKET FOR DEMENTIA FOR, BY COUNTRY, 2022–2029 (USD MILLION) 182
6.5.3 ALZHEIMER’S DISEASE 182
6.5.3.1 Favorable initiatives and increased access to screening to drive market 182
TABLE 74 MENTAL HEALTH SCREENING MARKET FOR ALZHEIMER’S DISEASE, BY COUNTRY, 2018–2021 (USD MILLION) 183
TABLE 75 MENTAL HEALTH SCREENING MARKET FOR ALZHEIMER’S DISEASE, BY COUNTRY, 2022–2029 (USD MILLION) 184
6.5.4 OTHER COGNITIVE DISORDERS 184
TABLE 76 MENTAL HEALTH SCREENING MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 185
TABLE 77 MENTAL HEALTH SCREENING MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 185
7 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD 186
7.1 INTRODUCTION 187
TABLE 78 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION) 187
TABLE 79 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION) 187
7.2 SELF-REPORTED QUESTIONNAIRES & SURVEYS 188
TABLE 80 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION) 188
TABLE 81 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 82 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018–2021 (USD MILLION) 189
TABLE 83 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022–2029 (USD MILLION) 190
7.2.1 BECK DEPRESSION INVENTORY (BDI) 190
7.2.1.1 Increasing prevalence of depression to drive demand for BDI 190
TABLE 84 MENTAL HEALTH SCREENING MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2018–2021 (USD MILLION) 191
TABLE 85 MENTAL HEALTH SCREENING MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2022–2029 (USD MILLION) 192
7.2.2 GENERALIZED ANXIETY DISORDER-7 (GAD-7) 192
7.2.2.1 Growing concerns regarding anxiety disorders in adults to boost market 192
TABLE 86 MENTAL HEALTH SCREENING MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2018–2021 (USD MILLION) 193
TABLE 87 MENTAL HEALTH SCREENING MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2022–2029 (USD MILLION) 194
7.2.3 HAMILTON ANXIETY RATING SCALE (HAM-A) 194
7.2.3.1 Increasing demand for standardized & reliable assessment tools to favor market growth 194
TABLE 88 MENTAL HEALTH SCREENING MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2018–2021 (USD MILLION) 195
TABLE 89 MENTAL HEALTH SCREENING MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2022–2029 (USD MILLION) 196
7.2.4 PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12) 196
7.2.4.1 Growing focus on early intervention to boost demand 196
TABLE 90 MENTAL HEALTH SCREENING MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2018–2021 (USD MILLION) 197
TABLE 91 MENTAL HEALTH SCREENING MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2022–2029 (USD MILLION) 198
7.2.5 YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS) 198
7.2.5.1 Rising awareness of obsessive compulsive disorder (OCD) to fuel growth 198
TABLE 92 MENTAL HEALTH SCREENING MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2018–2021 (USD MILLION) 199
TABLE 93 MENTAL HEALTH SCREENING MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2022–2029 (USD MILLION) 200
7.2.6 OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS 200
TABLE 94 MENTAL HEALTH SCREENING MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018–2021 (USD MILLION) 201
TABLE 95 MENTAL HEALTH SCREENING MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022–2029 (USD MILLION) 202
7.3 CLINICAL INTERVIEWS 202
TABLE 96 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION) 203
TABLE 97 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 98 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2018–2021 (USD MILLION) 204
TABLE 99 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2022–2029 (USD MILLION) 205
7.3.1 MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI) 205
7.3.1.1 Increasing global burden of psychiatric disorders to boost market growth 205
TABLE 100 MENTAL HEALTH SCREENING MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2018–2021 (USD MILLION) 206
TABLE 101 MENTAL HEALTH SCREENING MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2022–2029 (USD MILLION) 207
7.3.2 STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID) 207
7.3.2.1 Growing demand for comprehensive & detail assessment screening methods to favor market growth 207
TABLE 102 MENTAL HEALTH SCREENING MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2018–2021 (USD MILLION) 208
TABLE 103 MENTAL HEALTH SCREENING MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2022–2029 (USD MILLION) 209
7.3.3 DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD) 209
7.3.3.1 Increasing prevalence of psychological distress post pandemic to drive demand for DIPD 209
TABLE 104 MENTAL HEALTH SCREENING MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2018–2021 (USD MILLION) 210
TABLE 105 MENTAL HEALTH SCREENING MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2022–2029 (USD MILLION) 211
7.3.4 OTHER CLINICAL INTERVIEWS 211
TABLE 106 MENTAL HEALTH SCREENING MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2018–2021 (USD MILLION) 212
TABLE 107 MENTAL HEALTH SCREENING MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2022–2029 (USD MILLION) 213
7.4 OBSERVATION-BASED ASSESSMENTS 213
7.4.1 ADVANCES IN WEARABLE TECHNOLOGIES TO REVOLUTIONIZE OBSERVATION-BASED ASSESSMENT TOOLS 213
TABLE 108 MENTAL HEALTH SCREENING MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2018–2021 (USD MILLION) 214
TABLE 109 MENTAL HEALTH SCREENING MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 215
7.5 BIOMARKER TESTING 215
7.5.1 ADVANCES IN ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING TO DRIVE ADOPTION OF BIOMARKER TESTING TECHNOLOGIES 215
TABLE 110 MENTAL HEALTH SCREENING MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2018–2021 (USD MILLION) 216
TABLE 111 MENTAL HEALTH SCREENING MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2022–2029 (USD MILLION) 217
8 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY 218
8.1 INTRODUCTION 219
TABLE 112 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 219
TABLE 113 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 219
8.2 SELF-SCREENING MHEALTH APPS 220
8.2.1 INCREASING AWARENESS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF MHEALTH APPS IN FUTURE 220
TABLE 114 MENTAL HEALTH SCREENING MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2018–2021 (USD MILLION) 221
TABLE 115 MENTAL HEALTH SCREENING MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2022–2029 (USD MILLION) 222
8.3 TELEHEALTH & VIRTUAL CARE SOLUTIONS 222
8.3.1 RISING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE SERVICES TO FUEL MARKET GROWTH 222
TABLE 116 MENTAL HEALTH SCREENING MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2018–2021 (USD MILLION) 223
TABLE 117 MENTAL HEALTH SCREENING MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 224
8.4 CONTINUOUS MONITORING WEARABLE DEVICES 224
8.4.1 SHIFT TOWARDS PROACTIVE AND PERSONALIZED HEALTHCARE TO DRIVE MARKET GROWTH 224
TABLE 118 MENTAL HEALTH SCREENING MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2018–2021 (USD MILLION) 225
TABLE 119 MENTAL HEALTH SCREENING MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 226
8.5 AI-BASED SCREENING TOOLS 226
8.5.1 HIGH COST ASSOCIATED WITH AI-BASED SCREENING TOOLS TO RESTRAIN MARKET GROWTH 226
TABLE 120 MENTAL HEALTH SCREENING MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2018–2021 (USD MILLION) 227
TABLE 121 MENTAL HEALTH SCREENING MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2022–2029 (USD MILLION) 228
8.6 REMOTE MENTAL HEALTH PLATFORMS 228
8.6.1 INCREASED ADOPTION OF REMOTE MENTAL HEALTH SCREENING PLATFORMS TO FAVOR MARKET GROWTH 228
TABLE 122 MENTAL HEALTH SCREENING MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2018–2021 (USD MILLION) 229
TABLE 123 MENTAL HEALTH SCREENING MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2022–2029 (USD MILLION) 230
9 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP 231
9.1 INTRODUCTION 232
TABLE 124 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 232
TABLE 125 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 232
9.2 CHILDREN & ADOLESCENTS (AGE 0–18 YEARS) 233
9.2.1 GROWING PREVALENCE OF MENTAL HEALTH DISORDERS IN CHILDREN & ADOLESCENTS TO DRIVE MARKET GROWTH 233
TABLE 126 MENTAL HEALTH SCREENING MARKET FOR CHILDREN & ADOLESCENTS (0–18 YEARS), BY COUNTRY, 2018–2021 (USD MILLION) 234
TABLE 127 MENTAL HEALTH SCREENING MARKET FOR CHILDREN & ADOLESCENTS (0–18 YEARS), BY COUNTRY, 2022–2029 (USD MILLION) 235
9.3 ADULTS (AGE 19–64 YEARS) 235
9.3.1 GROWING POPULARITY OF WORKPLACE WELLNESS PROGRAMS TO BOOST DEMAND FOR MENTAL HEALTH SCREENING 235
TABLE 128 MENTAL HEALTH SCREENING MARKET FOR ADULTS (AGE 19–64 YEARS), BY COUNTRY, 2018–2021 (USD MILLION) 236
TABLE 129 MENTAL HEALTH SCREENING MARKET FOR ADULTS (AGE 19–64 YEARS), BY COUNTRY, 2022–2029 (USD MILLION) 237
9.4 SENIORS (AGE 65 AND ABOVE) 237
9.4.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN AGE-RELATED MENTAL DISORDERS TO BOOST MARKET 237
TABLE 130 MENTAL HEALTH SCREENING MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2018–2021 (USD MILLION) 238
TABLE 131 MENTAL HEALTH SCREENING MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2022–2029 (USD MILLION) 239
 
10 MENTAL HEALTH SCREENING MARKET, BY SETTING 240
10.1 INTRODUCTION 241
TABLE 132 MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 241
TABLE 133 MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 241
10.2 CLINICAL SETTINGS 242
10.2.1 SHIFT TOWARDS PREVENTIVE AND PATIENT-CENTRED CARE TO DRIVE MARKET GROWTH 242
TABLE 134 MENTAL HEALTH SCREENING MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION) 242
TABLE 135 MENTAL HEALTH SCREENING MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 243
10.3 EDUCATIONAL INSTITUTIONS 243
10.3.1 GROWING INITIATIVES TO BOOST GROWTH 243
TABLE 136 MENTAL HEALTH SCREENING MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2018–2021 (USD MILLION) 244
TABLE 137 MENTAL HEALTH SCREENING MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 245
10.4 WORKPLACE/CORPORATE PROGRAMS 245
10.4.1 RISING MENTAL HEALTH CHALLENGES AND DUTY OF CARE TO DRIVE MARKET GROWTH 245
TABLE 138 MENTAL HEALTH SCREENING MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2018–2021 (USD MILLION) 246
TABLE 139 MENTAL HEALTH SCREENING MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2022–2029 (USD MILLION) 247
10.5 ONLINE PLATFORMS 247
10.5.1 ACCESSIBLE AND PERSONALIZED ASSESSMENTS TO DRIVE DEMAND 247
TABLE 140 MENTAL HEALTH SCREENING MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2018–2021 (USD MILLION) 248
TABLE 141 MENTAL HEALTH SCREENING MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2022–2029 (USD MILLION) 249
10.6 OTHER SETTINGS 249
TABLE 142 MENTAL HEALTH SCREENING MARKET FOR OTHER SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION) 250
TABLE 143 MENTAL HEALTH SCREENING MARKET FOR OTHER SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 251